logo-loader
ASX:IMM

Immutep Ltd

Receive alerts
Market:
ASX
Price
0.38 AUD
Day Change
2.70%
Market Cap:
$451.76 m
52 weeks high
0.42
52 weeks low
0.22

In brief

Immutep Ltd (ASX:IMM, NASDAQ:IMMP) is focused on the development of LAG-3 related immunotherapeutic products for the treatment of cancer and autoimmune disease.

The company's current lead product candidate is eftilagimod alpha, a soluble LAG-3 fusion protein (LAG-3Ig).